Two Sigma Investments’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Buy |
683,599
+168,996
| +33% | +$242K | ﹤0.01% | 2221 |
|
|
2025
Q1 | $823K | Sell |
514,603
-49,234
| -9% | -$78.8K | ﹤0.01% | 2233 |
|
|
2024
Q4 | $2.03M | Sell |
563,837
-264,653
| -32% | -$953K | ﹤0.01% | 1647 |
|
|
2024
Q3 | $4.72M | Sell |
828,490
-479,243
| -37% | -$2.73M | 0.01% | 1074 |
|
|
2024
Q2 | $6.04M | Buy |
1,307,733
+135,893
| +12% | +$628K | 0.01% | 875 |
|
|
2024
Q1 | $9.57M | Buy |
+1,171,840
| New | +$9.57M | 0.02% | 629 |
|
|
2023
Q4 | – | Sell |
-402,527
| Closed | -$749K | – | 3082 |
|
|
2023
Q3 | $749K | Sell |
402,527
-166,552
| -29% | -$310K | ﹤0.01% | 2018 |
|
|
2023
Q2 | $1.56M | Buy |
569,079
+305,815
| +116% | +$841K | ﹤0.01% | 1586 |
|
|
2023
Q1 | $827K | Buy |
263,264
+144,989
| +123% | +$455K | ﹤0.01% | 1895 |
|
|
2022
Q4 | $698K | Sell |
118,275
-77,484
| -40% | -$457K | ﹤0.01% | 1818 |
|
|
2022
Q3 | $1.72M | Sell |
195,759
-138,132
| -41% | -$1.21M | 0.01% | 1180 |
|
|
2022
Q2 | $2.52M | Buy |
333,891
+218,960
| +191% | +$1.65M | 0.01% | 1023 |
|
|
2022
Q1 | $2.79M | Buy |
+114,931
| New | +$2.79M | 0.01% | 1164 |
|
|
2021
Q4 | – | Sell |
-21,073
| Closed | -$942K | – | 2631 |
|
|
2021
Q3 | $942K | Buy |
21,073
+10,100
| +92% | +$451K | ﹤0.01% | 1722 |
|
|
2021
Q2 | $415K | Buy |
+10,973
| New | +$415K | ﹤0.01% | 2027 |
|